bpc 157 typical dose subcutaneous injury healing BPC-157 Dosing (Common Protocols) πΉ Oral / β’ 500 mcg daily β’ Duration: 6 weeks πΉ Intramuscular / Peritendinous β’ 1 mg daily β’ Duration: 6 weeks β οΈ Note: Not approved What Is BPC-157? A Medical
Description
6 The peptide has demonstrated efficacy in healing transected muscles and restoring myotendinous junctions in animal models
The clearance of mutants from calf tissue at the end point (18 WPI) was in accordance with disappearance of mutants from feces at timepoints closer to the euthanasia (14 and 16 WPI)
As you can see, while all three are studied for 'healing,' their pathways are distinct
Adequate support when oral supplements aren't sufficient: Ideal for cases of nutrient absorption issues, diet limitations, or when you want a proactive boost
